CAPR Competitors & Alternatives
Compare Capricor Therapeutics Inc with similar stocks in the same industry
Biotechnology
CAPR
Main Stock$29.58
Tradestie Score
54
Market Cap
$357.51M
Revenue Growth
-0.1%
Analyst Upside
+82.9%
Top Competitors
226 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$30.00
|
$1.81B | - | 61 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.14
|
$1.78B | - | 55 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$17.37
|
$1.78B | - | 49 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.69
|
$1.74B | - | 59 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$30.58
|
$1.68B | - | 52 | Compare |
|
MNKD
Mannkind Corporation
|
$3.31
|
$1.65B | - | 60 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$32.69
|
$1.63B | - | 55 | Compare |
|
BHVN
Biohaven Ltd.
|
$9.48
|
$1.57B | - | 51 | Compare |
|
VCEL
Vericel Corporation
|
$35.15
|
$1.56B | 82.3 | 59 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$89.63
|
$1.55B | - | 58 | Compare |
More CAPR Analysis
Data updated: May 21, 2026 | Industry: Biotechnology (SIC 2834)
226 stocks in this industry